Pharmaceuticals
Fifty percent recruitment milestone for PROPELLER prostate cancer trial
SYDNEY, Dec. 1, 2021 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the growing needs in oncology, is pleased to announce that 15 of 30 participants have been recruited in the diagnostic64...
2021-12-01 21:57
721
Licensing Partner of Shenzhen Chipscreen Biosciences - HUYABIO International, Receives Regulatory Approval for Chidamide Monotherapy of Peripheral T-Cell Lymphoma(PTCL) in Japan
SHENZHEN, China, Dec. 1, 2021 /PRNewswire/ -- Shenzhen Chipscreen Biosciences' licensing partner, HUYABIO International (HUYABIO™), today announced the regulatory approval for Chidamide (Tucidinostat, also known as Epidaza ®, Hiyasta®, HBI-8000) monotherapy for the treatment of relapsed or refrac...
2021-12-01 21:54
871
Binhai New Area to spearhead China's medical industry development
TIANJIN, China, Nov. 30, 2021 /PRNewswire/ -- Here's a news report from chinadaily.com.cn: By 2025, the Binhai New Area in North China's Tianjin municipality will cultivate industry clusters worth tens of billions of yuan that are dedicated to pharmaceuticals, biotech, medical devices, diagnosti...
2021-12-01 11:20
673
Ascentage Pharma and Innovent Biologics Announce Approval for China's First Third-Generation BCR-ABL TKI Olverembatinib, Marking a Clinical Breakthrough in the Treatment of Chronic Myeloid Leukemia
SUZHOU, China and ROCKVILLE, Md., Nov. 30, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, and Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-...
2021-12-01 08:00
302
Standigm signs MOU with Institut Pasteur Korea for AI-based drug discovery research on infectious disease
SEOUL, South Korea, Nov. 30, 2021 /PRNewswire/ -- Standigm Inc. ("Standigm"), the leading workflow artificial intelligence (AI) drug discovery company, today announced the signing of a Memorandum of Understanding ("MOU") with Institut Pasteur Korea ("IPK"), the infectious disease-focused research...
2021-11-30 21:30
592
ABM Therapeutics Receives IND Approval in China for BRAF Inhibitor ABM-1310
SAN DIEGO and SHANGHAI, Nov. 30, 2021 /PRNewswire/ -- ABM Therapeutics (ABM), a clinical-stage biopharmaceutical company with a focus on treating brain cancers and cancer metastases, today announced that its IND application for ABM-1310, a new-generation BRAF inhibitor, has been approved by the N...
2021-11-30 13:00
782
GBM AGILE Opens to Paxalisib in Canada
SYDNEY, Nov. 29, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an oncology-focused drug development company, is pleased to inform stakeholders that the GBM AGILE study in glioblastoma (NCT03970447) has opened at Sunnybrook Health Sciences Centre inToronto, Ontario. Thi...
2021-11-29 22:05
1505
OriCiro Genomics Launches New enzymatic DNA synthesis tool for commonly used vectors
TOKYO, Nov. 29, 2021 /PRNewswire/ -- OriCiro Genomics Inc., a pioneer in cell-free synthesis and amplification of genome-scale large DNA for advanced therapeutics and synthetic biology, today announced the launch of OriCiro® Cell-Free Switching system. In the biological sciences, cell-based clon...
2021-11-29 22:00
814
PharmaBlock Appointed Dr. Wenfang Miao as Chief Executive Officer
NANJING, China, Nov. 29, 2021 /PRNewswire/ -- PharmaBlock (300725.SZSE), an innovative chemistry products and services provider to support drug discovery, development, and commercialization, announced today that the former Senior Vice President of Quality, Dr.Wenfang Miao, is appointed as the com...
2021-11-29 20:00
679
ST Pharm announces expansion of oligonucleotide facility, taking a leap towards the world's largest oligonucleotide CDMO
SEOUL, South Korea, Nov. 29, 2021 /PRNewswire/ -- On November 24, ST Pharm Co. Ltd., an API CDMO company in Republic of Korea, announced to build the second oligonucleotide manufacturing plant for an expansion of production facilities and to preoccupy the rapidly growing oligonucleotide therapeut...
2021-11-29 20:00
559
Ascentage Pharma Appoints Mr. Yiqing Chen as Chief Financial Officer
SUZHOU, China, and ROCKVILLE, MD., Nov. 29, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced the appointment of Mr.Yiqing Chen as Chief Financ...
2021-11-29 19:01
871
Tang Prize Laureates Reflect on the Breakthroughs Made Possible by Cytokine Research
TAIPEI, Nov. 27, 2021 /PRNewswire/ -- Following the inspiring opening speech, "Future Perspective of Cancer Immunotherapy," delivered by Nobel Prize and Tang Prize laureate Prof.Tasuku Honjo at the 14th Asia Pacific Federation of Pharmacologist Conference (APFP) onNovember 26, the 2020 Tang Prize...
2021-11-27 16:00
3500
IASO Biotheraputics' CT120 Granted Orphan Drug Designation by the U.S. FDA
SAN JOSE, Calif., NANJING, China and SHANGHAI, Nov. 25, 2021 /PRNewswire/ -- IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company focusing on discovering, developing, and manufacturing innovative medicine announcedon Oct 26, 2021 that the Office of Orphan Products Developme...
2021-11-26 11:05
833
Biotron Drug Effective Against COVID-19 In Animals
* BIT225 administered orally significantly reduced viral load in the lungs and blood of animals challenged with SARS-CoV-2. * BIT225 protected against severe disease, indicated by the significant prevention of body weight loss in animals treated with BIT225 compared to non-treated controls. ...
2021-11-25 19:00
1172
Kintor Pharma Receives IND Clearance by NMPA for KX-826's Pivotal Study to Treat Male Alopecia Patients
SUZHOU, China, Nov. 24, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced that the IND application for the pivotal study (phase III stage) of p...
2021-11-24 23:14
1480
Neurophth Therapeutics Strengthens Leadership Team with Appointment of Su Zhang as Chief Financial Officer
SHANGHAI and SAN DIEGO, Nov. 24, 2021 /PRNewswire/ -- Neurophth Biotechnology Ltd., a fully-integrated genomic medicines company seeking to improve lives through the curative potential of gene therapies, today announced the recent appointment ofSu Zhang, M.B.A., as the Chief Financial Officer (CF...
2021-11-24 21:30
1106
GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing
BOSTON and INCHEON, South Korea, Nov. 24, 2021 /PRNewswire/ -- GreenLight Biosciences (Nasdaq: ENVI), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture, and Environmental Impact Acquisition Corp, and Samsung Biol...
2021-11-24 20:00
939
Amgen and Bushu Pharma Announce Expanded Supply Chain Partnership across Japan and Asia-Pacific Region
KAWAGOE, Japan, Nov. 24, 2021 /PRNewswire/ -- Bushu Pharmaceuticals Ltd. ("Bushu Pharma") has agreed on an expanded partnership with Amgen Inc. and Amgen K.K. to provide its "Gateway toAsia" service to four countries across the Asia-Pacific region as Amgen's contract manufacturing organization (C...
2021-11-24 15:00
809
Everest Medicines Announces Inclusion in the MSCI Global Small Cap Indexes - MSCI China Index
SHANGHAI, Nov. 23, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest" or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inAsia, today announced that th...
2021-11-24 08:00
1006
Gracell Biotechnologies Announces Senior Management Team Share Purchase Plan
SUZHOU, China and PALO ALTO, Calif., Nov. 23, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell" or the "Company"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, toda...
2021-11-23 22:00
1736
Week's Top Stories
Most Reposted
Sojung Lee Appointed as New President for the Asia-Pacific Region at TeamViewer
[Picked up by 155 media titles]
2021-12-01 09:00
The Filmore Da Nang by Filmore to Launch in Hong Kong
[Picked up by 154 media titles]
2021-11-25 12:00
Joy Spreader Announces Unaudited Results for the First Three Quarters of 2021
[Picked up by 146 media titles]
2021-11-30 13:16Next.e.GO Mobile electric vehicle manufacturer announces the appointment of new CEO
[Picked up by 142 media titles]
2021-12-01 16:01
Moldova Sets its Sights on Global Innovation Leadership, with Top-Level Support from the President and Prime Minister and Frontier Innovators the US and Sweden
[Picked up by 141 media titles]
2021-11-29 09:00
Most Read
Ucommune International Ltd. Announces Unaudited Third Quarter 2021 Financial Results
2021-11-26 19:30
6999
The Filmore Da Nang by Filmore to Launch in Hong Kong
2021-11-25 12:00
4844
Reserves And Resources Update
2021-11-26 22:00
4697
Tantech Subsidiary Wins RMB 50 Million Factoring Agreement
2021-11-26 21:00
4419